Skip to content
BIO Events
BIO Start-Up Stadium 2024: Meet Emerging Company winner Neuroene Therapeutics
Neuroene Therapeutics is developing mitochondrial-protective small molecules for epilepsy, Parkinson’s, and mitochondrial diseases. The company’s CEO Sherine Chan, Ph.D., co-founded Neuroene with medicinal chemist C. ...
Read More
Latest News
LATEST STORIES
BIO's View
BIO’s view: Sanders’ latest attack on innovation misses realities about groundbreaking drugs
Yesterday, Sen. Bernie Sanders held a meeting about the new class of groundbreaking diabetes and weight-loss medicines. Next week, he will hold a hearing on ...
BIO's View
Four key facts ahead of tomorrow’s drug pricing hearing
The Senate Finance Committee will hold a hearing tomorrow on “understanding the benefits of the Inflation Reduction Act.” Expect to hear a lot of rhetoric about ...
Agriculture
House members seek to block new wildlife refuge rules regarding GE crops
Members of Congress discussed legislation to block proposed federal rules that would regulate growth of genetically engineered crops on wildlife refuges during a Sept. 10 ...
WHAT YOU MISSED AT THE LATEST BIO EVENTS
BIO Start-Up Stadium 2024: Meet Emerging Company winner Neuroene Therapeutics
Neuroene Therapeutics is developing mitochondrial-protective small molecules for epilepsy, Parkinson’s, and mitochondrial diseases. The company’s CEO Sherine Chan, Ph.D., co-founded Neuroene with medicinal chemist C. ...
Read More
BIO Start-Up Stadium 2024: Meet Seed-Stage winner Afreen Allam and SiNON Nano Sciences
Afreen Allam’s company, SiNON Nano Sciences, has been working tirelessly to overcome one of the most significant challenges in neurology: enabling drugs to cross the ...
Read More